FeesSafety
Pluang+

Tether holds minimal assets at EQIBank amid U.S. seizure of $84M linked to Capstone accounts.

Market News
25 Sep 2026
Crypto news
View Source
Bearish
Tether holds minimal assets at EQIBank amid U.S. seizure of $84M linked to Capstone accounts.

Tether confirmed it holds less than 0.034% of its assets at EQIBank, an offshore bank facing U.S. asset seizure related to Capstone-linked accounts totaling about $84.2 million. EQIBank claims the seized funds represent 80% of its monetary holdings and warns of liquidation risks. U.S. prosecutors are pursuing forfeiture, and a federal judge denied EQIBank's motion to recover the funds. Tether's overall reserves remain strong, with $187.75 billion in assets and a $4.11 billion excess reserve buffer as of June 2026. The legal case continues in the Eastern District of California, with no final judgment yet on the seized funds' ownership.

Tether's exposure to EQIBank is below 0.034%, according to recent disclosures. For readers following cryptocurrency markets, here is Pluang's market snapshot as of Sep 25, 2026 13:01 WIB: out of 50 major cryptocurrencies priced on Pluang, 42 rose and 7 fell today. Notable movers include XLM (Stellar) at Rp3.928 with an 8.36% increase, EOS (EOS.IO) at Rp12.649 up 8.13%, and SAND (The Sandbox) at Rp785 rising 7.79%.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
35 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App